Providing IPS-based Platforms for Pharma & Research Institutions

Providing IPS-based Platforms for Pharmaceutical & Research Institutions

High-Volume Manufacturing

We produce cells with
consistency on the order
of billions per lot
Expansion

We expand human
iPS cells from
millions to billions
Differentiation

We make iPS-derived
human cardiac and neuronal cells
Shaping

We shape cells
into biologically
relevant microOrgans^®
Plating

We provide bulk cells
or as pre-plated
assays for high throughput screening

More Info on Services

Cells

StemoniX^® manufactures human cardiac and neuronal cells for drug toxicity and efficacy testing

iPS Cells

Human induced pluripotent stem cells Request Info >
Cardiac Cells

Physiologically accurate cardiac cells Request Info >
Neuronal Cells

Glutamatergic and GABAergic neurons and astrocytes Request Info >

More About Human Cells

Drug Screening Plates

StemoniX^® can put any individual on a plate

microHeart^®

Passively self-aligned cardiac cells to match native human heart tissue structure Request Info >
microBrain^®

Functional neuronal circuity available in standard and MEA microplate formats Request Info >

More About Screening Plates

The simple things make a difference in how we help you

Human
Human induced pluripotent stem cells (hiPSC) and hiPSC-derived organ cells

Bio-Relevant
We structure and accelerate biology through passive technologies

Economical
Our automation and passive technologies enable us to be the low cost leader

Ready-to-Use
Our screening plates arrive ready-to-use with minimal need for culturing cells

Ambient Shipping
Our plates can be shipped globally at ambient conditions

Consistent
We’ve developed fully automated, high volume manufacturing processes that enable consistent lots of up to 1 billion cells

Questions? Ask Us

Miniaturizing, commercializing and personalizing stem cells

StemoniX^® makes ready-to-use high-throughput screening plates designed with human microHearts^® and microBrains^® for drug discovery and development. This effort is revolutionizing stem cell-based research and drug screening, leading to a new era of drug discovery and personalized medicine.

More About StemoniX

Why StemoniX?

We grow, differentiate, and print organ cells from skin cells, in a way that makes them biologically accurate, to better predict their toxicity and improve efficacy.

Blue: DNA staining of fibroblasts highlighting their nuclei

Red: Phalloidin staining of Actin Cytoskeleton

Our technology includes the ability to create a variety of organ cells that can mimic diseases to help accelerate the discovery of new cures in the areas of heart disease, dementia and neuromuscular diseases.

	Well Range	High-Throughput	Cost	Induce Disease
StemoniX	96 - 1536	Yes	$	Yes
Competitors	<100	No	$$$	No

StemoniX

Revolutionizing the production, growth, and development of stem cell and stem cell technologies.

Scaling Human Stem Cells

StemoniX is setting a new standard for stem cell technologies to make microOrgans biologically relevant

Providing IPS-based Platforms for Pharma & Research Institutions

Providing IPS-based Platforms for Pharmaceutical & Research Institutions

Cells

StemoniX^® manufactures human cardiac and neuronal cells for drug toxicity and efficacy testing

iPS Cells

Cardiac Cells

Neuronal Cells

Drug Screening Plates

StemoniX^® can put any individual on a plate

microHeart^®

microBrain^®

The simple things make a difference in how we help you

Miniaturizing, commercializing and personalizing stem cells

StemoniX^® makes ready-to-use high-throughput screening plates designed with human microHearts^® and microBrains^® for drug discovery and development. This effort is revolutionizing stem cell-based research and drug screening, leading to a new era of drug discovery and personalized medicine.

Why StemoniX?

We grow, differentiate, and print organ cells from skin cells, in a way that makes them biologically accurate, to better predict their toxicity and improve efficacy.

Our technology includes the ability to create a variety of organ cells that can mimic diseases to help accelerate the discovery of new cures in the areas of heart disease, dementia and neuromuscular diseases.

Why StemoniX?

About Us

Our team and scientific board have vetted StemoniX IP with over $200M and a track record of success

Meet the StemoniX Team

MS, MBA, PMP, PgMP, Ping has formed and led teams to producing world-changing devices. His expertise focuses on merging core intellectual property from startups to F100 corporations.

Dr. Bob Petcavich, Cofounder & Chief Science Advisor of StemoniX, is a successful serial inventor and entrepreneur, holding nearly 60 patents.

PhD in cell-based assays for high throughput cancer drug discovery. A leader at the Dept. of Medicine & Division of Cardiology at University of California, San Diego.

MD MBA FACEP, Dr. Khaleghi has led the personalized medicine process for WellnessFX as their medical director. He has also served as CMIO of the Noble Health System, and published 6 health books.

StemoniX Connections:

Providing IPS-based Platforms for Pharma & Research Institutions

Providing IPS-based Platforms for Pharmaceutical & Research Institutions

Cells

StemoniX® manufactures human cardiac and neuronal cells for drug toxicity and efficacy testing

iPS Cells

Cardiac Cells

Neuronal Cells

Drug Screening Plates

StemoniX® can put any individual on a plate

microHeart®

microBrain®

The simple things make a difference in how we help you

Miniaturizing, commercializing and personalizing stem cells

StemoniX® makes ready-to-use high-throughput screening plates designed with human microHearts® and microBrains® for drug discovery and development. This effort is revolutionizing stem cell-based research and drug screening, leading to a new era of drug discovery and personalized medicine.

Why StemoniX?

We grow, differentiate, and print organ cells from skin cells, in a way that makes them biologically accurate, to better predict their toxicity and improve efficacy.

Our technology includes the ability to create a variety of organ cells that can mimic diseases to help accelerate the discovery of new cures in the areas of heart disease, dementia and neuromuscular diseases.

Why StemoniX?

About Us

Our team and scientific board have vetted StemoniX IP with over $200M and a track record of success

Meet the StemoniX Team

MS, MBA, PMP, PgMP, Ping has formed and led teams to producing world-changing devices. His expertise focuses on merging core intellectual property from startups to F100 corporations.

Dr. Bob Petcavich, Cofounder & Chief Science Advisor of StemoniX, is a successful serial inventor and entrepreneur, holding nearly 60 patents.

PhD in cell-based assays for high throughput cancer drug discovery. A leader at the Dept. of Medicine & Division of Cardiology at University of California, San Diego.

MD MBA FACEP, Dr. Khaleghi has led the personalized medicine process for WellnessFX as their medical director. He has also served as CMIO of the Noble Health System, and published 6 health books.

StemoniX Connections:

StemoniX^® manufactures human cardiac and neuronal cells for drug toxicity and efficacy testing

StemoniX^® can put any individual on a plate

microHeart^®

microBrain^®

StemoniX^® makes ready-to-use high-throughput screening plates designed with human microHearts^® and microBrains^® for drug discovery and development. This effort is revolutionizing stem cell-based research and drug screening, leading to a new era of drug discovery and personalized medicine.